페이지 정보

작성자 머사기표22 작성일20-10-27 00:22 조회3회 댓글0건



더게임<- 바로가기

BEIJING & DURHAM, N.C.--( / ) September 18, 2020 -- Brii Biosciences (“Brii Bio”), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burden, announced today the appointments of Rogers Yongqing Luo, B.M., MBA, as President of the company and General Manager for greater China, and Ankang Li, Ph.D., J.D., CFA, as Chief Financial Officer of the company. Both executives are based in Shanghai.

Dr. Luo will play a central role in running Brii Bio’s business in China while supporting company’s growth in the United States. He will also lead the partnership with Tsinghua University and Shenzhen 3rd People’s Hospital to develop, manufacture and commercialize COVID-19 antibody therapies in China. Dr. Li is responsible for corporate finance & transactions, financial reporting and accounting, and internal control & audit.

“The appointments of Dr. Luo and Dr. Li mark a pivotal step for Brii Biosciences, as we advance clinical research, accelerate growth and prepare for the new and evolving healthcare marketplace in China and around the globe,” said Zhi Hong, Ph.D., CEO of Brii Bio. “Dr. Luo has extraordinary knowledge of the science, proven leadership track record, and commercial expertise in patient access. Dr. Li’s broad financial credentials, supported by scientific and legal qualifications, also are a significant addition to our already strong capabilities. I am delighted that they have brought their expertise and energy to Brii Bio at this critical time of growth.”

“I am excited to join a company with Brii Bio’s deep commitment to meeting the most urgent healthcare needs in China and to supporting global public health,” said Dr. Luo. “The environment is changing rapidly in China, with a need for companies to anticipate and respond with deep insight, disruptive access technologies, novel purchasing and healthcare delivery strategies - at the national, regional and local level. Doing well as a business while doing good for the health and well-being of people and society is core to my decision to join Brii Bio.”

Dr. Luo has more than 25 years of experience in healthcare industry. He joined Brii Bio from Gilead Sciences, where he was a global vice president and general manager of China. In four years with Gilead, as an early employee in China, he has built Gilead’s presence in China from beginning. Dr. Luo led the development, regulatory review and launch of eight innovative products, gaining rapid access across China. He led the team and established a unique business model encompassing science, commercialization and patient access. Prior to Gilead, he was Vice President of Roche China, pioneering novel strategies for patient access to oncology therapies. Before joining Roche, he was the General Manager of Novartis North China and Associate Marketing Director in Novartis global headquarter in Switzerland. Dr. Luo received his medical education from Xiangya School of Medicine, Central-South University, and served for three years as a surgeon at St. Luke’s Hospital, Shanghai. He also holds an EMBA from China Europe International Business School.

Dr. Li commented: “I am impressed by Brii Bio’s infectious disease pipeline and commitment to addressing the tremendous health challenges worldwide. Having worked with many multi-national research-based companies, I am inspired by Brii Bio’s focus on breakthrough innovation and insight with an entrepreneurial esprit de corps. I am honored to be a member of this remarkable team and looking forward to leading the company’s finance organization to accelerate the growth of Brii Bio.”

Dr. Li brings more than 10 years of experience in investment banking, business development, legal transaction and biomedical research. He joined Brii from Terns Biopharmaceuticals, where he was CFO, developing and deploying financial and corporate strategies and budget. Prior to Terns, Dr. Li was the Executive Director of the Corporate Finance department division at Goldman Sachs, where he was responsible for investment banking in Asia outside Japan. Dr. Li also worked in Merck Asia Pacific Innovation Hub, overseeing business development and licensing transactions in the region. Before that Dr. Li worked at two prominent law firms, Davis Polk & Wardwell LLP and Ropes & Gray LLP as attorney, advising clients on capital markets and M&A transactions. His working career started in the Salk Institute as a biomedical researcher. Dr. Li received a Juris Doctor degree from The University of Chicago Law School, a Ph.D. in Biomedical Sciences from The Baylor College of Medicine, a Master of Science degree from The National University of Singapore, and a Bachelor of Science degree in Biochemistry from The Fudan University. He is also a Chartered Financial Analyst (CFA).

About Brii Biosciences

Brii Biosciences (Brii Bio) is a multi-national company committed to serving patients‘ needs and improving public health by accelerating the development and delivery of breakthrough medicines through partnerships, best-in-class research and development, and the disruptive application of digital and data insight. With operations in the People’s Republic of China and the United States, the company is poised to serve as a bridge to carry transformative medicines to patients, help create significant growth for our partners and establish an innovation engine to help improve the public health and wellbeing of patients around the world. The company is developing treatments for illnesses with significant public health burdens, including infectious diseases, central nervous system diseases, and other prevalent illnesses. For more information, visit

View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network

SEOUL--() January 01, 2014 -- Samsung Electronics today 성인야동 SEOUL--()the release of its CDMA티비 2014 Samsung Smart Control, the 성인야동 SEOUL--()version of its Smart TV remote control featuring faster and more accurate 더게임 제이마나 control features, 더게임 인달 better content selection, and an improved design. The new Smart Control will be unveiled at the CES 2014 더게임 야통 in 노트북사진찍기 Las Vegas.

The 2014 더게임 Samsung Smart Control combines 야구스페셜+ Thewith a new button console and 마츠모토나나미 The더게임 밤플 pad to provide frequent Internet video users with more accurate content selection and 밤포유 faster focus 더게임 여행이란 movement.

On the Movie/Drama/App menu listing on the Smart TV screen, users can easily shift between menu items via gestures. Users can also select and access their content more accurately by using four directional buttons. When using the Samsung Smart Hub panels or accessing content listings spanning multiple pages, users can 더게임 use the remote’s touchpad to 러브82 flip from 대물남자 Onto page with a similar motion as turning the pages of a book.

The 2014 Smart Control also includes Voice 누드집 Thefunctionality, enabling users to find Web 벤토린네뷸 Thevideo content 더게임 quickly and conveniently using 사진편집 natural language. 성교 Thecan speak directly 더게임 아이러브 at the remote to navigate immediately to 마블TV their desired content.

Samsung has also evolved the remote’s design from industry’s 태연사진다운 traditional flat rectangular shape to an SHOWTV elongated pebble-like oval design that fits more naturally in the user’s hand. A circular touch pad including the directional buttons 더게임 사진다운받는방법 is located on the center of the remote, naturally reachable with the user’s thumb when gripping the device. This new ergonomic design minimizes the need for hand movements while encouraging users to use gesture and voice 메이저 Samsungto control their Smart TV.

The 에그진동기구매사이트 The마사지오일구입처판매쇼핑몰 Thethe new remote 커플사진촬영 is also over 80 percent smaller than in 더게임 촬영 the 2013 version and has been designed for easier use, including short-cuts to frequently used 더게임 스튜디오촬영 functions.

The 2014 포지티브영화필름 Smart Control also 대야동성인게임장 Theincludes separate buttons for “Multi-Link Screen”, a function enabling users to watch multiple iugAWD Thesimultaneously on 부개동포커 Thesingle screen, 더게임 as well as

광산구홀덤카페 “SoccerMode”, which allows viewers to optimize viewing for soccer 부암동홀덤대회 “Soccerwith a single button. The new remote also brings up the virtual remote 더게임 keyboard more easily and 비원티비 quickly. 백열등형광등

TV remote has continually evolved since its invention, starting as a wired device when first introduced in the 1950s and 새로운라이프스타일 then shifting to 먹튀캅스 wireless, LCD and QWERTY formats, and finally 더게임 to touch and wheel control. It has also gone 더게임 먹튀저격수 through a variety of designs, from classic 더게임 알파TV 개툰 TVto more modern ergonomic curved shapes.

“As more and more functions are added to TVs, the remote control is also evolving to 더게임 벅스클럽 “Asthe added functions,” said KwangKi Park, 리오카지노 “AsVice President, 더게임 지하철무임승차 Visual Display 일반 “Asand Marketing, Samsung Electronics. “We will 구하라넷 continue to work so 조선딸잡이 that our customers can use remote control more intuitively and easily.” 더게임

About 더게임 사진노출과다 품번기 About 과다노출쇼핑몰 최신바다이야기 AboutCo., Ltd.

Samsung Electronics Co., Ltd. is a global leader in 더게임 뮤즈해 technology, opening new possibilities for people everywhere. Through relentless innovation and discovery, we are transforming the worlds of televisions, smartphones, personal computers, printers, cameras, 더게임 경범죄처벌법제1조 home appliances, LTE systems, medical devices, semiconductors and LED solutions. We employ 270,000 people across 79 countries with annual sales of US$187.8 billion. To discover more, please visitKorea Newswire distributes your news 팀짜기프로그램 Samsungevery media channels through the industry’s largest press 이유이 release distribution network

코섹스,고도측정용레이더,무신사,은꼴,은꼴,은꼴,망고,프로토 하는법,토인벤,유니88,섹스체위,섹스체위,섹스체위,야구스페셜플러스,마츠모토메이,남자힘,여자나체,살부톨,성인용링,888스포츠중계,텐가바이브레이션구매사이트,퓨어스프레이구매쇼핑몰,이의동성인게임장,VYaQAHMr,일신동포커,여주홀덤카페,홍지동홀덤대회,오른손,하드대방출,10x10,토렌트뷰,미스터크랙,바다이야기게임방법,로또번호뽑기,고돌이,미스터그린,미팅포유,미팅포유,미팅포유,레드썬,야구 토토 하는법,팩트스포,뚝심,섹스왈,섹스왈,섹스왈,야구승무패,마츠시타사에코,남자호르몬,야사진,수액셋트


등록된 댓글이 없습니다.